$164.80

-1.64 (-0.99%)
Live
Previous Close

$164.8

Day Range

$163.79 - $166.91

Previous Day Range

$162.99 - $169

Market Cap

$12.9 billion USD

Day Vol.

706820

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Ico...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Clinical research organization ICON reported better-than-expected Q2 financial results, with quarterly sales of $2.02 billion and adjusted earnings of $3.26 per share. The company raised its fiscal 2025 sales guidance and expanded its share buyback program to $1 billion.

Related tickers: ICLR.

Read Full Article

The global regulatory affairs outsourcing market is expected to grow significantly from 2024 to 2030, driven by the globalization of biopharmaceutical and medical device companies and the need for specialized regulatory expertise. Technological advancements in regulatory processes are also shaping the market.

Related tickers: G, MEDP, CRL, ICLR, WUXAY.

Read Full Article
Trending Tickers

Please sign in to view